“CTI represents a perfect fit for Sobi’s haematology ... rights to a breast cancer therapy being developed by Scorpion Therapeutics. Join the conversation, on Tuesday 28th January @ 10 am ...
such as the recently launched FoRx Therapeutics—focused on DNA Replication Stress, a subcategory of DNA Damage Response, an emerging science area within CTI and of strategic interest for our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results